Skip Navigation

Adalvo nominated as finalist in five Global Generics & Biosimilars 2022 Awards

30 September 2022

At Adalvo we are driven by our relentless passion and commitment to our partner network. We tirelessly strive for excellence in all of our endeavors, driven by a deep-rooted passion to making a difference for partners and improve the lives of patients around the world.

We are thrilled to announce details about our latest achievement. Adalvo has been nominated as a finalist, in five Awards, by the Global Generics & Biosimilars Awards 2022 Committee, within the following categories:

  • Company of the Year
  • Value Added Medicine Initiative of the Year
  • Regulatory Achievement of the year
  • CSR Initiative of the Year
  • Industry Partner of the Year

Winners will be announced at the Awards ceremony taking place on Wednesday 2nd November at the Frankfurt Marriott Hotel, Germany.

We look forward to seeing you there!